Internet-Delivered Psychological Treatments for Chronic Pain in Adolescents: ACT and Pain Education.

NARecruitingINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

May 31, 2025

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2027

Conditions
Chronic PainNociplastic PainPain ManagementAcceptance and Commitment TherapyCognitive Behavior Therapy
Interventions
BEHAVIORAL

Acceptance and Commitment Therapy

Participants receive a 9-week internet-delivered intervention: 2 weeks of Pain Neuroscience Education (PNE) based on the PSE curriculum, followed by 7 weeks of Acceptance and Commitment Therapy (ACT) targeting psychological flexibility. In addition to value-oriented behavioral activation, the ACT content includes classical exposure. The treatment is mainly text-based, supported by multimedia content, and delivered on a secure digital platform. Communication with a clinician occurs at least weekly. Parents receive a parallel program based on PSE, ACT, and behavioral principles to support flexible and effective parenting.

BEHAVIORAL

Pain Science Education

Participants receive 9 weeks of internet-delivered Pain Science Education (PSE), based on the PSE curriculum but with more detailed content, including extended examples, reflection exercises, and behavioral experiments. The aim is to reduce the threat value of pain by promoting a reconceptualization of pain. Parents receive a parallel program with tailored content. The intervention is text-based with multimedia components and delivered via a secure platform. Clinician support is provided asynchronously at least once weekly.

Trial Locations (1)

18647

RECRUITING

Karolinska University Hospital, Vallentuna

All Listed Sponsors
collaborator

Karolinska Institutet

OTHER

collaborator

Forskningsrådet för hälsa, arbetsliv och välfärd (FORTE)

UNKNOWN

lead

Region Stockholm

OTHER_GOV

NCT06981312 - Internet-Delivered Psychological Treatments for Chronic Pain in Adolescents: ACT and Pain Education. | Biotech Hunter | Biotech Hunter